While we identified reduced CSF p-tau among both PD groups vs. HC, which was consistent with multiple studies16, the changes in Aβ42 and fractalkine were unexpected and in the opposite direction than those seen in comparisons of AD and HC. This evidence concerns the gene CX3CL1 and Parkinson disease.